This article has been updated from a previous version to include information on the company's stock price.

NEW YORK (GenomeWeb News) - Agilent Technologies yesterday reported that revenues for its Bio-analytical segment declined 8 percent in its third fiscal quarter as total revenues fell 27 percent.

For the three months ended July 31, Agilent posted total revenues of $1.06 billion, a 27 percent falloff from $1.4 billion in the year-ago period but an improvement over analyst estimates of $1.02 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.